Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_provenance.
- NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_assertion description "[Overexpression of PPARdelta or activation of PPARdelta by its pharmacological ligand, GW501516, at low doses (0.5-50 nM) promoted the growth of three human cholangiocarcinoma cell lines (CCLP1, HuCCT1, and SG231).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_provenance.
- NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_assertion evidence source_evidence_literature NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_provenance.
- NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_assertion SIO_000772 16966336 NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_provenance.
- NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_assertion wasDerivedFrom befree-20150227 NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_provenance.
- NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_assertion wasGeneratedBy ECO_0000203 NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP797101.RAyw5YOIevL_HgIPsTSGxQUsxMAVLxJiOPVyDlq1nsLs4130_provenance.